EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunological profile of acute Chagas disease patients infected via oral transmission and treated with Benznidazole: a two-year follow-up of immune responses

Luciane de Freitas Firmino, Victor Vaitkevicius-Antão, Amanda Vasconcelos Nascimento, Cíntia Nascimento Costa-Oliveira, Michelle da Silva Barros, Diego José Lira Torres, Claudeir Dias Silva-Junior, Byannca de Carvalho Torreão, Maria Beatriz Araújo Silva, Carolina de Araújo de Medeiros, Tayne Fernanda Lemos da Silva, Maria Aucineide Basílio Albuquerque und 8 weitere

Immunobiology · 2026

DOI: 10.1016/j.imbio.2026.153169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunobiology, 2026. Verfasst von Luciane de Freitas Firmino und 19 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de Pernambuco (UFPE), Recife, Brazil. Hauptthemen laut MEDLINE: Nitroimidazoles, Chagas Disease, Trypanosoma cruzi, Trypanocidal Agents. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The state of Pernambuco, Brazil, reported its biggest outbreak of Acute Chagas disease (ACD) caused by oral transmission, in 2019. During the acute phase, timely access to treatment must be quick and performed in all cases, regardless of the transmission route, as approximately 70-80% of cases are cured. Monitoring the immunological profile after Benznidazole (BZ) treatment in ACD patients may help identify tools to support disease progression assessment. This study aimed to evaluate the immune response, especially cytokines and antibodies levels, in patients with ACD and treated with BZ. A total of 28 laboratory-confirmed patients from the outbreak were included. Th1 and Th2 cytokines were quantified in serum samples using flow cytometry, and antibody levels were assessed by indirect immunofluorescence. Our findings indicate that BZ reduced the inflammatory response, as evidenced by decreased levels of Th1-type cytokines (IFN-γ, TNF, IL-2 and IL-6). Anti-inflammatory cytokines (IL-4 and IL-10) also showed a decline following treatment. Only IgM antibody titers were reduced, with no consistent pattern observed for IgG. These results support the use of BZ in acute phase and suggest the potential use of cytokines as auxiliary biomarkers for therapeutic monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NitroimidazolesChagas DiseaseTrypanosoma cruziTrypanocidal AgentsHumansFemaleCytokinesMaleAdultFollow-Up StudiesAcute DiseaseAntibodies, ProtozoanMiddle AgedTh1 CellsBrazilBiomarkersTh2 Cells

Stichwörter der Autor:innen

AntibodyCytokinesLongitudinal monitoring

Substanzen

benzonidazoleNitroimidazolesCytokinesAntibodies, ProtozoanTrypanocidal AgentsBiomarkers

Autor:innen und Institutionen

  • Universidade Federal de Pernambuco (UFPE), Recife, Brazil.
  • Fundação Oswaldo Cruz-Fiocruz, Instituto Aggeu Magalhães, Fiocruz Pernambuco, Recife, Brazil.
  • Fundação de Hematologia e Hemoterapia de Pernambuco (HEMOPE), Recife, Brazil.
  • Universidade Federal de Pernambuco (UFPE), Recife, Brazil; Fundação Oswaldo Cruz-Fiocruz, Instituto Aggeu Magalhães, Fiocruz Pernambuco, Recife, Brazil.
  • Faculdade de Enfermagem Nossa Senhora das Graças, Universidade de Pernambuco (UPE), Recife, Brazil.
  • Ambulatório de Doença de Chagas e Insuficiência Cardíaca do Pronto Socorro Cardiológico de Pernambuco, Recife, Brazil.

Zitieren

APA

Firmino, L. F., Vaitkevicius-Antão, V., Nascimento, A. V., Costa-Oliveira, C. N., Barros, M. D. S., Torres, D. J. L., Silva-Junior, C. D., Torreão, B. C., Silva, M. B. A., Medeiros, C. A., Silva, T. F. L. D., Albuquerque, M. A. B., Silva, M. M. M., Batista, F. P., Montenegro, D., Oliveira-Júnior, W., Carrazzone, C., Martins, S. M., Soares, A. K. A., & Lorena, V. M. B. (2026). Immunological profile of acute Chagas disease patients infected via oral transmission and treated with Benznidazole: a two-year follow-up of immune responses. Immunobiology. https://doi.org/10.1016/j.imbio.2026.153169

Vancouver

Firmino LF, Vaitkevicius-Antão V, Nascimento AV, Costa-Oliveira CN, Barros MDS, Torres DJL, et al. Immunological profile of acute Chagas disease patients infected via oral transmission and treated with Benznidazole: a two-year follow-up of immune responses. Immunobiology. 2026. doi:10.1016/j.imbio.2026.153169

BibTeX
@article{Firmino2026,
  author = {Firmino, Luciane de Freitas and Vaitkevicius-Antão, Victor and Nascimento, Amanda Vasconcelos and Costa-Oliveira, Cíntia Nascimento and Barros, Michelle da Silva and Torres, Diego José Lira and Silva-Junior, Claudeir Dias and Torreão, Byannca de Carvalho and Silva, Maria Beatriz Araújo and Medeiros, Carolina de Araújo de and Silva, Tayne Fernanda Lemos da and Albuquerque, Maria Aucineide Basílio and Silva, Milena Maria de Morais and Batista, Filipe Prohaska and Montenegro, Demetrius and Oliveira-Júnior, Wilson de and Carrazzone, Cristina and Martins, Silvia Marinho and Soares, Ana Karine Araújo and Lorena, Virginia Maria Barros de},
  title = {Immunological profile of acute Chagas disease patients infected via oral transmission and treated with Benznidazole: a two-year follow-up of immune responses},
  journal = {Immunobiology},
  year = {2026},
  doi = {10.1016/j.imbio.2026.153169}
}
Kostenlos starten →